Literature DB >> 16452525

Role of peripheral innervation in p-chloroamphetamine-induced ejaculation in anesthetized rats.

Pierre Clément1, Hossein K Kia, Stephane Droupy, Jacques Bernabe, Laurent Alexandre, Pierre Denys, François Giuliano.   

Abstract

The occurrence of ejaculation, which consists of 2 distinct phases (emission and expulsion), requires a tight coordination of peripheral autonomic and somatic nerves. However, some aspects of the mechanism of ejaculation are not clearly defined. To clarify this issue, we used the p-chloroamphetamine (PCA)-induced ejaculation model in anesthetized rats and investigated the effects of selective peripheral nerves lesions on seminal vesicle and bulbospongiosus (BS) muscle activities as representing physiological markers of emission and expulsion phases, respectively. In intact rats, ejaculation induced with PCA (intraperitoneal 5 mg/kg) correlated with coordinated increases in seminal vesicle pressure (SVP) and BS electromyographic activity. PCA-induced ejaculation was still observed in rats with bilateral lesion of hypogastric nerves (HNx), lumbar paravertebral sympathetic chain (LSCx), or dorsal nerves of the penis (DNPx). Conversely, bilateral section of pelvic nerves (PNx) or L6-S1 dorsal roots (DRx) abolished PCA-induced ejaculation. The amplitude of SVP increases induced by PCA was reduced in PNx, HNx, and LSCx rats, whereas it was unchanged in DRx and DNPx rats. The time interval between SVP increases and BS muscle contractions induced by PCA was comparable in the different neural lesion groups. In conclusion, PCA initiates both emission and expulsion independently from each other. In this model, afferents conveyed by the pelvic nerves appear to be unnecessary for occurrence of BS muscle contractions but are essential for a complete ejaculatory response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452525     DOI: 10.2164/jandrol.05163

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  1 in total

1.  Spontaneous ejaculation with the use of noradrenergic reuptake inhibitors.

Authors:  Ingrid Oosterhuis; Léon Heijting; Eugène van Puijenbroek
Journal:  Eur J Clin Pharmacol       Date:  2012-03-23       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.